NO932670L - Blandinger - Google Patents

Blandinger

Info

Publication number
NO932670L
NO932670L NO93932670A NO932670A NO932670L NO 932670 L NO932670 L NO 932670L NO 93932670 A NO93932670 A NO 93932670A NO 932670 A NO932670 A NO 932670A NO 932670 L NO932670 L NO 932670L
Authority
NO
Norway
Prior art keywords
mixtures
intranasal
methanesulfonamide
headache
solvate
Prior art date
Application number
NO93932670A
Other languages
English (en)
Norwegian (no)
Other versions
NO932670D0 (no
Inventor
Joanne Craig
David Alistair Saynor
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO932670D0 publication Critical patent/NO932670D0/no
Publication of NO932670L publication Critical patent/NO932670L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
NO93932670A 1991-01-24 1993-07-23 Blandinger NO932670L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919102579A GB9102579D0 (en) 1991-01-24 1991-01-24 Compositions
PCT/EP1992/000094 WO1992012712A1 (fr) 1991-01-24 1992-01-19 Compositions

Publications (2)

Publication Number Publication Date
NO932670D0 NO932670D0 (no) 1993-07-23
NO932670L true NO932670L (no) 1993-07-23

Family

ID=10689660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93932670A NO932670L (no) 1991-01-24 1993-07-23 Blandinger

Country Status (8)

Country Link
US (1) US5393773A (fr)
EP (1) EP0496308A1 (fr)
JP (1) JPH06504991A (fr)
AU (1) AU653986B2 (fr)
CA (1) CA2100569A1 (fr)
GB (1) GB9102579D0 (fr)
NO (1) NO932670L (fr)
WO (1) WO1992012712A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP2005281315A (ja) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc 水性薬理組成物
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6132757A (en) 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6426084B1 (en) 2000-06-19 2002-07-30 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
DE10064950A1 (de) * 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropes Nasenspray
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6562838B2 (en) * 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US20030096748A1 (en) * 2001-06-04 2003-05-22 The Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
US7041677B2 (en) * 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
US7208628B2 (en) * 2002-05-13 2007-04-24 Kansas State University Research Foundation Compositions and methods for the treatment of hepatitis C virus infection
US7074893B2 (en) * 2002-06-03 2006-07-11 Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
US20040219229A1 (en) * 2003-04-30 2004-11-04 Tim Clarot Migraine relief composition and methods of using and forming same
US20050089558A1 (en) * 2003-10-28 2005-04-28 Alamo Pharmaceuticals, Llc Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
US20060002989A1 (en) * 2004-06-10 2006-01-05 Ahmed Salah U Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
DE102006020604A1 (de) * 2006-05-02 2007-11-08 Bayer Healthcare Ag Flüssige Arzneimittelformulierung
US8653066B2 (en) 2006-10-09 2014-02-18 Charleston Laboratories, Inc. Pharmaceutical compositions
US20080275030A1 (en) * 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
EP2240022B1 (fr) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Comprimés à deux couches contenant oxycodone et promethazine
EP2451274B1 (fr) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Compositions pharmaceutiques
NZ599344A (en) 2009-09-25 2015-02-27 Reddy’S Lab Ltd Dr Formulations comprising triptan compounds
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
JP6897971B2 (ja) 2015-05-15 2021-07-07 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 関節炎を処置するための、方法および組成物
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
WO2018200014A1 (fr) * 2017-04-24 2018-11-01 Levine Joshua D Procédé de contraception au moyen d'un fluide plastique de bingham thixotropique
WO2019094469A1 (fr) 2017-11-07 2019-05-16 The Regents Of The University Of Michigan Inhibiteurs à petites molécules inhibant des interactions partagées épitope-calréticuline et méthodes d'utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133691B (en) * 1983-01-21 1986-05-21 Leo Ab Smoking substitutes for nasal administration
EP0187433B1 (fr) * 1983-08-01 1990-12-27 Teijin Limited Composition pharmaceutique poudreuse pour l'application sur la muqueuse de la cavité orale ou nasale
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations

Also Published As

Publication number Publication date
AU1165292A (en) 1992-08-27
NO932670D0 (no) 1993-07-23
AU653986B2 (en) 1994-10-20
US5393773A (en) 1995-02-28
WO1992012712A1 (fr) 1992-08-06
CA2100569A1 (fr) 1992-07-25
GB9102579D0 (en) 1991-03-27
EP0496308A1 (fr) 1992-07-29
JPH06504991A (ja) 1994-06-09

Similar Documents

Publication Publication Date Title
AU575612B2 (en) (piperidine-4-yl-amino)-benzimidazoles/imida-20 pyrines
MX9102209A (es) Derivados de acido hidroxamico y n-hidroxiurea novedosos y su uso.
LU90160I2 (fr) Naratriptan facultativement sous la forme d'un sel pharmaceutiquement acceptable ou d'un solvate y compris le chlorhydrate de naratriptan
EP0354777A3 (fr) Dérivés du 3-(4-pipéridine)-5-(2-sulfonylaminoéthyl)-indole
FI963424A0 (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
NO941937L (no) Sakarinderivater som inhiberer proteolytiske enzymer
NO963053L (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
IL104154A0 (en) Saccharin derivatives,their preparation and pharmaceutical compositions containing them
ATE104145T1 (de) 4-substituierten imidazolen zur senkung des intraokularen druckes.
RU95105435A (ru) N-замещенные производные 3-азабицикло [3.2.0]гептана в качестве нейролептического средства
NO943895L (no) Galantaminderivater, en fremgangsmåte for fremstilling samt deres anvendelse som medikamenter
DK149852C (da) Analogifremgangsmaade til fremstilling af substituerede 3-aminosydnoniminer eller et farmakologisk acceptabelt syreadditionssalt deraf
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
RU94031479A (ru) Новое применение производных аминокислот, способ лечения, фармацевтическая композиция
FR2767527B1 (fr) Derives de piperazines indoliques, utiles comme medicaments et procede de preparation
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
FI932654A0 (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
NO985974L (no) Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer
ES2035915T3 (es) Agentes antiarritmicos n-fenetil-aminoalquil-benzamida.
NO20013601L (no) Nye morfolinobenzamidsalter
AU4831279A (en) New compounds
ATE186912T1 (de) Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen
MY103509A (en) Indole derivatives.